4[10]Imoto S,Murakami K,Ikeda H,et al.Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer[J].Ann Nucl Med,1999,13:325-329.
5[11]Borgstein PJ,Pijpers R,Comans EF,et al.Sentinel lymph node biopsy in breast cancer:guidelines and pitfalls of lymphoscintigraphy and gamma probe detection[J].J Am Coll Surg,1998,186:275-283.
6[12]Flett MM,Going JJ,Stanton PD,et al.Sentinel node localization in patients with breast cancer[J].Br J Sury,1998,85:991-993.
7[15]Krag D,Weaver D,Ashikaga T,et al.The sentinel node in breast cancer:a multicenter validation study[J].N Engl J Med,1998,339:941-946.
8[17]Cady B.Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients[J].J Sury Oncol,2001,77:149-152.
9[18]Shimazu K,Tamaki Y,Taguchi T,et al.Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer[J].Surgery,2002,131:277-286.
10[19]Borgstein PJ,Meijer S,Pijpers RJ,et al.Functional lymphatic anatomy for sentinel node biopsy in breast cancer:echoes from the past and periareolar blue method[J].Ann Sury,2000,232:81-89.
